Sorry to burst your bubble, but USRM has no rights to SDF1. They lost that deal years ago. SDF1 is 100% owned by Cleveland clinic and that break up did not go well for then Bioheart!!! That is a blatant lie. I know this, personally, to be factual. I’m sure the SEC will/or already has homed in on this lie noted in the 10-Q. You know nothing factual about this company. Clinical trials for Myocell will cost them easy $200 mil, not to mention the staff needed to run the clinical trials. No partnership will happen. USRM is a liability and in a legal mess. Nobody would ever partner with them. If someone was interested in partnering with them they would have received the money years ago. Know your facts!!!